Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Sunday, June 5, 2016

C Diff infection

HIPPO - June 2016
"Heidi James sits down with infectious disease specialist Dan Smythe to break down C Diff infection: Are some antibiotics worse than others when it comes to causing C Diff? What’s the ideal first line treatment? How often do patients relapse?...
  • C. diff is a bacteria whose potent toxins are responsible for the clinical sequelae.
  • The hardy C. diff spores are resistant to commonly used cleansers and disinfectants.
  • Clinical criteria are used to characterize the severity of infections. Fever, WBC>15,000 and renal failure are associated with more severe forms of the disease.
  • C. diff accounts for about 25% of antibiotic-associated diarrhea. 
  • Third generation cephalosporins, quinolones, and clindamycin are antibiotics high-risk for causing C. diff. Lower-risk antibiotics include doxycycline and macrolides.
  • The initial treatment of patients with mild-moderate C. diff is oral/IV metronidazole. For those with severe symptoms, start with oral vancomycin.
  • 30% of patients will fail initial therapy for C. diff; this is a disease often characterized by relapse and recurrence.
  • Patients with a 3rd recurrence of C. diff may benefit from a 6-8 week vancomycin tapering regimen. Those with a 4th recurrence may be offered fecal transplantation."